Result of Fundraise

Summary by AI BETAClose X

Renalytix plc successfully raised gross proceeds of £5.20 million through a placing and subscription of 54,741,582 new Ordinary Shares at a price of 9.5 pence per share. The placing was significantly oversubscribed. Four company directors subscribed for an aggregate of 2,815,789 shares, amounting to approximately £267,500. Application has been made for admission to the London Stock Exchange, with settlement of 9,253,679 First Tranche Placing Shares expected around September 26, 2025, and settlement of the 45,487,903 Second Tranche Placing Shares expected around September 29, 2025. Following admission, the Company will have 385,947,594 Ordinary Shares in issue.

Disclaimer*

UK 100

Latest directors dealings